Chapter/Section Purchase

Leave This Empty:

Global Biopharmaceutical CMO & CRO Market Insights and Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biologics
1.2.3 Biosimilars
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Contract Manufacturing
1.3.3 Contract Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO & CRO Market Perspective (2017-2028)
2.2 Biopharmaceutical CMO & CRO Growth Trends by Region
2.2.1 Biopharmaceutical CMO & CRO Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biopharmaceutical CMO & CRO Historic Market Size by Region (2017-2022)
2.2.3 Biopharmaceutical CMO & CRO Forecasted Market Size by Region (2023-2028)
2.3 Biopharmaceutical CMO & CRO Market Dynamics
2.3.1 Biopharmaceutical CMO & CRO Industry Trends
2.3.2 Biopharmaceutical CMO & CRO Market Drivers
2.3.3 Biopharmaceutical CMO & CRO Market Challenges
2.3.4 Biopharmaceutical CMO & CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue (2017-2022)
3.1.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Players (2017-2022)
3.2 Global Biopharmaceutical CMO & CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical CMO & CRO Revenue
3.4 Global Biopharmaceutical CMO & CRO Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO & CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO & CRO Revenue in 2021
3.5 Biopharmaceutical CMO & CRO Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical CMO & CRO Product Solution and Service
3.7 Date of Enter into Biopharmaceutical CMO & CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO & CRO Breakdown Data by Type
4.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Type (2017-2022)
4.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical CMO & CRO Breakdown Data by Application
5.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Application (2017-2022)
5.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biopharmaceutical CMO & CRO Market Size (2017-2028)
6.2 North America Biopharmaceutical CMO & CRO Market Size by Type
6.2.1 North America Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
6.2.2 North America Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
6.2.3 North America Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
6.3 North America Biopharmaceutical CMO & CRO Market Size by Application
6.3.1 North America Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
6.3.2 North America Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
6.3.3 North America Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
6.4 North America Biopharmaceutical CMO & CRO Market Size by Country
6.4.1 North America Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
6.4.2 North America Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO & CRO Market Size (2017-2028)
7.2 Europe Biopharmaceutical CMO & CRO Market Size by Type
7.2.1 Europe Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
7.2.2 Europe Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
7.2.3 Europe Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
7.3 Europe Biopharmaceutical CMO & CRO Market Size by Application
7.3.1 Europe Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
7.3.2 Europe Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
7.3.3 Europe Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
7.4 Europe Biopharmaceutical CMO & CRO Market Size by Country
7.4.1 Europe Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
7.4.2 Europe Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size (2017-2028)
8.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
8.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
8.4 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO & CRO Market Size (2017-2028)
9.2 Latin America Biopharmaceutical CMO & CRO Market Size by Type
9.2.1 Latin America Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
9.2.2 Latin America Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
9.2.3 Latin America Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
9.3 Latin America Biopharmaceutical CMO & CRO Market Size by Application
9.3.1 Latin America Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
9.3.2 Latin America Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
9.3.3 Latin America Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
9.4 Latin America Biopharmaceutical CMO & CRO Market Size by Country
9.4.1 Latin America Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
9.4.2 Latin America Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size (2017-2028)
10.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
10.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
10.4 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biopharmaceutical CMO & CRO Introduction
11.1.4 Lonza Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.1.5 Lonza Recent Developments
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Company Details
11.2.2 Boehringer Ingelheim GmbH Business Overview
11.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Introduction
11.2.4 Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.2.5 Boehringer Ingelheim GmbH Recent Developments
11.3 Rentschler Biotechnologie GmbH
11.3.1 Rentschler Biotechnologie GmbH Company Details
11.3.2 Rentschler Biotechnologie GmbH Business Overview
11.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Introduction
11.3.4 Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.3.5 Rentschler Biotechnologie GmbH Recent Developments
11.4 Inno Biologics Sdn Bhd
11.4.1 Inno Biologics Sdn Bhd Company Details
11.4.2 Inno Biologics Sdn Bhd Business Overview
11.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Introduction
11.4.4 Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.4.5 Inno Biologics Sdn Bhd Recent Developments
11.5 JRS Pharma (Celonic GmbH)
11.5.1 JRS Pharma (Celonic GmbH) Company Details
11.5.2 JRS Pharma (Celonic GmbH) Business Overview
11.5.3 JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Introduction
11.5.4 JRS Pharma (Celonic GmbH) Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.5.5 JRS Pharma (Celonic GmbH) Recent Developments
11.6 BIOMEVA GmbH
11.6.1 BIOMEVA GmbH Company Details
11.6.2 BIOMEVA GmbH Business Overview
11.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Introduction
11.6.4 BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.6.5 BIOMEVA GmbH Recent Developments
11.7 ProBioGen
11.7.1 ProBioGen Company Details
11.7.2 ProBioGen Business Overview
11.7.3 ProBioGen Biopharmaceutical CMO & CRO Introduction
11.7.4 ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.7.5 ProBioGen Recent Developments
11.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
11.8.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
11.9 TOYOBO CO., LTD
11.9.1 TOYOBO CO., LTD Company Details
11.9.2 TOYOBO CO., LTD Business Overview
11.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Introduction
11.9.4 TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.9.5 TOYOBO CO., LTD Recent Developments
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Details
11.10.2 Samsung BioLogics Business Overview
11.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Introduction
11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.10.5 Samsung BioLogics Recent Developments
11.11 Patheon
11.11.1 Patheon Company Details
11.11.2 Patheon Business Overview
11.11.3 Patheon Biopharmaceutical CMO & CRO Introduction
11.11.4 Patheon Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.11.5 Patheon Recent Developments
11.12 CMC Biologics
11.12.1 CMC Biologics Company Details
11.12.2 CMC Biologics Business Overview
11.12.3 CMC Biologics Biopharmaceutical CMO & CRO Introduction
11.12.4 CMC Biologics Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.12.5 CMC Biologics Recent Developments
11.13 Binex Co., Ltd.
11.13.1 Binex Co., Ltd. Company Details
11.13.2 Binex Co., Ltd. Business Overview
11.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Introduction
11.13.4 Binex Co., Ltd. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.13.5 Binex Co., Ltd. Recent Developments
11.14 AbbVie Inc.
11.14.1 AbbVie Inc. Company Details
11.14.2 AbbVie Inc. Business Overview
11.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Introduction
11.14.4 AbbVie Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.14.5 AbbVie Inc. Recent Developments
11.15 WuXi Biologics.
11.15.1 WuXi Biologics. Company Details
11.15.2 WuXi Biologics. Business Overview
11.15.3 WuXi Biologics. Biopharmaceutical CMO & CRO Introduction
11.15.4 WuXi Biologics. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.15.5 WuXi Biologics. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer